Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Yonsei Medical Journal ; : 196-200, 2006.
Artículo en Inglés | WPRIM | ID: wpr-113991

RESUMEN

The objective of this study was to investigate the correlation between factor XIII (FXIII) activity and disseminated intravascular coagulation (DIC) parameters and also to evaluate the clinical usefulness of DIC diagnosis. Citrated plasma from eighty patients with potential DIC was analyzed for FXIII activity. The primary patient conditions (48 male and 32 female, mean age, 51 years) were malignancy (n = 29), infection (n = 25), inflammation (n = 6), heart disease (n= 3), thrombosis (n = 2), injury (n = 2), and other miscellaneous conditions (n = 13). FXIII testing was performed using the CoaLinkTM FXIII Incorporation Assay Kit (PeopleBio Inc.). Among 80 patients who were suspected to have DIC based on clinical analysis, 46 (57.5%) fulfilled the overt DIC criteria (DIC score > = 5) according to the International Society of Thrombosis and Haemostasis. FXIII levels in the plasma were significantly decreased in overt DIC compared to non-overt DIC patients (mean 75.1% and 199.7% respectively, p < 0.0001). Interestingly, we found a significant inverse correlation between DIC scores and FXIII activity. In addition, FXIII activity significantly correlated with other hemostatic markers that included platelet count, prothrombin time, activated partial thromboplastin time, fibrinogen, and D-dimer. FXIII levels were significantly lower in patients with liver or renal dysfunction. In conclusion, FXIII cross-linking activity measurements may have differential diagnostic value as well as predictive value in patients who are suspected to have DIC.


Asunto(s)
Persona de Mediana Edad , Masculino , Humanos , Femenino , Anciano , Adulto , Tiempo de Protrombina , Recuento de Plaquetas , Tiempo de Tromboplastina Parcial , Hepatopatías/patología , Hígado/patología , Enfermedades Renales/patología , Riñón/patología , Inflamación , Hemostasis , Productos de Degradación de Fibrina-Fibrinógeno/biosíntesis , Factor XIII/biosíntesis , Coagulación Intravascular Diseminada/sangre , Reactivos de Enlaces Cruzados/farmacología , Pruebas de Coagulación Sanguínea
2.
Yonsei Medical Journal ; : 201-206, 2006.
Artículo en Inglés | WPRIM | ID: wpr-113990

RESUMEN

Procoagulant or impaired fibrinolytic states as well as inflammatory reactions mediated by cytokines are likely involved in the pathogenesis of acute ischemic stroke. We examined the potential relationship between interleukin 6 (IL-6) and hemostatic markers. The procoagulant and fibrinolytic states were assessed in 46 patients with acute stroke by measuring plasma levels of plasminogen activator inhibitor-1 (PAI-1), thrombin-antithrombin complex (TAT), and plasminogen-antiplasmin complex (PAP). Circulating IL-6 levels were measured using ELISA (Quantikine, R and D systems, MN, USA). Circulating IL-6 (mean, 26.5 pg/mL) and PAI-1 (mean, 19.9 ng/mL) levels were higher in patients with acute stroke than in healthy subjects (mean, 3.0 pg/mL, 10.4 ng/mL, respectively). TAT levels were statistically different according to the etiologic subtypes of stroke (atherogenic, 2.5 ng/mL; lacunar 3.2 ng/mL; cardiogenic 9.9 ng/mL, p = 0.021). Neither procoagulant levels nor fibrinolytic markers significantly correlated with circulating IL-6 levels. Our findings suggest that elevated proinflammatory cytokines during the initial hours of ischemic stroke may be an independent pathogenic factor or a consequence of the thrombotic event with no relationship to the procoagulant or fibrinolytic states.


Asunto(s)
Persona de Mediana Edad , Masculino , Humanos , Femenino , Anciano , Trombosis , Terapia Trombolítica , Trombina/química , Inhibidor 1 de Activador Plasminogénico/sangre , Fosfolípidos/química , Modelos Estadísticos , Isquemia/sangre , Interleucina-6/sangre , Hemostasis , Fibrinólisis , Ensayo de Inmunoadsorción Enzimática , Citocinas/metabolismo , Coagulantes/metabolismo , Accidente Cerebrovascular/sangre , Factores de Coagulación Sanguínea/metabolismo , Antitrombinas/química , Enfermedad Aguda
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA